<DOC>
	<DOCNO>NCT01229761</DOCNO>
	<brief_summary>The purpose study find way improve infant health survival among infant whose mother HIV-infected HIV .</brief_summary>
	<brief_title>Study Improve Survival Among HIV-Exposed Infants Botswana</brief_title>
	<detailed_description>As improve MTCT prevention intervention reduce number HIV-infected infant antepartum peripartum period , intervention improve HIV-free survival among HIV-uninfected infant need . Morbidity mortality increase among HIV-uninfected infant bear HIV-infected mother , reduce infant survival among HIV-exposed infant may lead many death HIV infection . In Botswana , use formula feed short breastfeeding may worsen problem early infant mortality among HIV-exposed infant . The study enroll pregnant postpartum HIV-1-infected woman , HIV-uninfected infant Botswana . At 2-4 week age , live HIV-uninfected infant randomize receive either double-blinded cotrimoxazole ( CTX ) placebo 2-4 week 15 month . In addition , breastfeeding ( BF ) infant randomize BF either 6 12 month age . Children follow prospectively 18 month age . The primary endpoint survival 18 month compare infant CTX vs. placebo arm , randomize duration BF among BF randomization . Secondary endpoint evaluate survival morbidity/mortality 12 15 month ; HIV-free survival 18 month ; safety CTX prophylaxis . Secondary observational objective include compare MTCT mortality initial feeding method ( formula feeding BF &gt; 1 month ) , analysis maternal characteristic predictor initial feeding choice HIV-free survival . All woman infant receive standard antenatal peripartum prophylaxis Botswana government MTCT prevention ( PMTCT ) , choose feed method counseling . Breastfeeding infant receive infant nevirapine ( NVP ) prophylaxis protect MTCT use maternal HAART .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<criteria>HIVinfected woman , &gt; 26 week gestation &lt; 34 day postpartum . Women must Â¬ &gt; 18 year age willing/able sign inform consent . Women infant must able follow regularly study clinic 18 month postpartum . For Feeding Randomization Only : Women must willing breastfeed 12 month , stop 6 month , depend upon feed assignment . Antepartum woman : Known infant anomaly result high probability infant survive 18 month . Postpartum woman : Known HIVinfected infant , infant medical condition make survival 18 month unlikely .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>Trimethoprim-Sulfamethoxazole Combination</keyword>
	<keyword>Breast Feeding</keyword>
	<keyword>Infant Mortality</keyword>
	<keyword>Morbidity</keyword>
	<keyword>Botswana</keyword>
	<keyword>Africa</keyword>
	<keyword>Infectious disease transmission , vertical</keyword>
	<keyword>adverse drug event</keyword>
</DOC>